Antiallergic Metabolite Production from Plants via Biotechnological Approaches

Allergic disorders pose a significant global health challenge, impacting millions. Plants, rich in bioactive compounds, have gained recognition for their potential to alleviate various allergic symptoms. The demand for effective antiallergic agents has spurred research into harnessing the therapeutic potential of plant-derived metabolites. Therefore, as the need for sustainable, nature-based therapeutic options grows, biotechnological strategies have become powerful tools for amplifying the production of antiallergic metabolites. This chapter delves into biotechnological approaches for producing antiallergic metabolites from plants. Specifically, the study investigates the use of in vitro systems, such as callus and cell suspension cultures, as well as elicitor interventions, to augment the production of secondary metabolites exhibiting antiallergic properties. The integration of genetic fidelity assessment and molecular techniques ensures the quality and consistency of the produced compounds. Researchers have employed in vitro systems to yield secondary metabolites targeting allergic responses by leveraging plants’ inherent capabilities and advanced techniques. The chapter sheds light on methodologies aimed at bolstering the production of compounds targeting allergic reactions, encompassing antiasthmatic, antihistaminic, and anti-itching agents. This chapter contributes to understanding innovative strategies for harnessing plant-derived compounds to combat allergies by offering insights into these biotechnological methodologies. Besides, our study aims to equip researchers, practitioners, and healthcare professionals with a roadmap to navigate the promising plant antiallergic metabolite production horizon.